ProPhase Labs (PRPH) EBIAT: 2010-2025
Historic EBIAT for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -$6.8 million.
- ProPhase Labs' EBIAT fell 3.83% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.3 million, marking a year-over-year decrease of 81.40%. This contributed to the annual value of -$53.4 million for FY2024, which is 217.98% down from last year.
- According to the latest figures from Q3 2025, ProPhase Labs' EBIAT is -$6.8 million, which was down 52.93% from -$4.5 million recorded in Q2 2025.
- In the past 5 years, ProPhase Labs' EBIAT registered a high of $12.5 million during Q1 2022, and its lowest value of -$34.4 million during Q4 2024.
- In the last 3 years, ProPhase Labs' EBIAT had a median value of -$6.2 million in 2024 and averaged -$7.8 million.
- Data for ProPhase Labs' EBIAT shows a peak YoY increase of 1,140.18% (in 2021) and a maximum YoY decrease of 2,092.86% (in 2021) over the last 5 years.
- ProPhase Labs' EBIAT (Quarterly) stood at $10.6 million in 2021, then slumped by 123.08% to -$2.4 million in 2022, then crashed by 258.06% to -$8.8 million in 2023, then slumped by 292.63% to -$34.4 million in 2024, then dropped by 3.83% to -$6.8 million in 2025.
- Its last three reported values are -$6.8 million in Q3 2025, -$4.5 million for Q2 2025, and -$4.7 million during Q1 2025.